DOSSIER · 13F-HR · Q1 2026

Propel Bio Management, LLC

Propel Bio's family office based in Chicago, IL $159M in tracked AUM across 38 positions as of Q1 2026.

PB
Propel Bio·Chicago, IL·Family Office
CIK 0001969764 · last filed Mar 31, 2026
Total AUM
$159M
18.9%
vs prior
Holdings
38
positions
Whale Score
59
59
tracked
Activity
no data
changes this Q
Top sector
Health Care
6% weight
concentration
AI Analysis · Q1 2026 · Q1 2026

SEC 13F Filing Analysis: Propel Bio Management, LLC

Report Period: Q3 2025 (Ending September 30, 2025)

1. Portfolio Overview

Propel Bio Management, LLC manages a concentrated portfolio totaling approximately $80.53 million across 12 holdings. The firm’s strategy is characterized by high conviction and low diversification, with the top four positions comprising nearly 64% of the total assets under management (AUM). During the third quarter of 2025, the firm executed a sig...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
PAGP
PLAINS GP HLDGS L P
$30M1.3M19.0%
02
ACHV
ACHIEVE LIFE SCIENCES INC
$11M3.8M7.2%
03
PHAT
PHATHOM PHARMACEUTICALS INC
$9M841K5.9%
04
DCTH
DELCATH SYS INC
$9M980K5.8%
05
CORT
CORCEPT THERAPEUTICS INC
$6M148K3.8%
06
ABEO
ABEONA THERAPEUTICS INC
$6M1.3M3.8%
07
VOR
VOR BIOPHARMA INC
$6M315K3.5%
08
KYTX
KYVERNA THERAPEUTICS INC
$6M644K3.5%
09
MIST
MILESTONE PHARMACEUTICALS IN
$5M4.1M3.2%
10
CLDX
CELLDEX THERAPEUTICS INC NEW
$4M131K2.6%

Filing history

Filing history loading…